Paracetamol Flashcards
What class of agent is paracetamol and why
It has been classified as a Non-steroidal anti-inflammatory drug due to its analgaesic and anti-pyretic properties despite having no effect on cyclo-oxygenase.
Proposed mechanism is CNS prostaglandin synthesis by inhibition of CNS COX-3, a COX 1 variant
What are the proposed mechanisms of action of paracetamol
- CNS COX 3 INHIBITION
Inhibition of COX 3 in the central nervous system. COX-3 is described as a variant of the COX 1 enzyme. Therefore the proposed mechanism of action is inhibition of prostaglandin synthesis in the central nervous system. - INHIBITION of CNS PROSTAGLANDIN F
- ACTIVITY AT CANNABINOID RECEPTORS IN SPINAL CORD
- SERITONERGIC SYSTEM MODULATION
Describe presentation paracetamol
- 500 mg tablets
- Combination with weak opioids (various)
- Paed: 120 mg/5 ml syrup
- IV: 1g or 500 mg in 100 ml clear colourless over 15 mins
- -> 10mg/ml paracetamol
- -> Preservative: Cysteine hydrochloride monohydrate
- -> Excipients: Mannitol + others
Describe the dosing of paracetamol and adjustments for renal/hepatic disease
Adult: 1 g 6 hourly (max 4g/day)
Children: 15 mg/kg/dose 6 hourly (max 60 mg/kg/day)
Neonate: 7.5 mg/kg/dose 6 hourly (max 30 mg/kg/day)
Describe the pharmacokinetics of paracetamol
ADME
Absorption
- Bioavailability 80%
- Peak [serum]: 1 hour tablets, 30 minutes syrup
Distribution
- Protein bound 20%
- Vd = 0.9 L/kg
Metabolism
- 95 % glucoronidation and sulfation
- 5 % CYP 2E1 –> NAPQI generated rapidly detoxified by glutathione (unless glutathione depleted)
Excretion
- Glucoronide, sulfate, cysteine conjugates excreted in urine
How is the oral bioavailability of paracetamol calculated.
Define bioavailability
List the factors that influence bioavailability
Draw plasma concentration - time curve
Bioavailability = AUC (oral) /AUC (IV)
Bioavailability is defined as the fraction of a drug dose reaching the systemic circulation, compared with the same dose given intravenously.
Factors influencing:
- Pharmaceutical properties (Particle size/binding agents)
- Physicochemical interactions (Ca+ - tetracyclines)
- Patient factors (Stasis/malabsorption/trauma)
- Pharmacokinetic interactions and 1st pass metabolism (Gut wall and liver)
FB = FA x FG x FH
FB - bioavailable fraction
FA - Fraction absorbed
FG - Fraction remaining after GIT metabolism
FH - Fraction remaining after HEPATIC metabolism
What does NAPQI stand for
N - acetyl - p - amino - benzoquinone
Describe the metabolic pathway of paracetamol toxicity
Paracetamol overdose –> glucoronidation and sulfation pathways saturated, metabolism proceeds via CYP 2E1 and CYP3A4 –> rapid glutathione depletion leading to accumulation of NAPQI:
- Inactivation of ± 20 important enzymes/proteins –> toxicity
- Inhibits mitochondrial cytochrome enzymes –> uncoupling of oxidative phosphorylation –> Failure ATP synthesis and release of sequestered calcium –> toxicity
–> HEPATOCELLULAR APOPTOSIS AND NECROSIS
Describe the mechanism of action of N-acetylcysteine (NAC)
N-acetylcysteine is converted to cysteine. This is combined to glutamate to form Glutamylcysteine. Glutamylcysteine is combined with Glycine to form more glutathione.
- Supplies more glutathione to bind to NAPQI
- Antioxidant
- Supplies sulfate from cysteine for more sulfation and less pracetamol down CYP 2E1 pathway
What is the recommended dosing schedule for NAC
How long is NAC given for
First hour: 150 mg/kg
Next 4 hours: 50 mg/kg
Next 16 hours: 100 mg/kg
Duration: at least 20 hours STOP if: 1. Paracetamol levels < 10 mg/L 2. ALT < 50 3. INR < 2 4. Patient clinically well
When does NAC no longer convey benefit in paracetamol overdose
After the onset of established liver failure (72 hours).
What can be used to assist decision making with regard to treating a paracetamol overdose
Prescott nomogram
Can the prescott nomogram be used if the sustained release paracetamol has been given?
NO
What dose and when should activated charcoal be given in paracetamol overdose
50 g within 4 hours of ingestion
50 g within 24 hours ingestion if sustained release taken
Which patients have depleted glutathione stores
- Eating disorders
- Prolonged starvation
- HIV
- Cystic Fibrosis
- G6PD deficiency